In Extensive Clinical Tests, Olumiant Continues to Show Efficacy in Atopic Dermatitis - BioSpace

In Extensive Clinical Tests, Olumiant Continues to Show Efficacy in Atopic Dermatitis  BioSpace

The investigational JAK inhibitor has hit the mark in three late-stage studies, with readouts from two more late-stage trials expected later this year.



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases